OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Okur-Chung neurodevelopmental syndrome (OCNS, MIM#617062) is a rare autosomal dominant syndrome related to CSNK2A1 mutations.
|
31729156 |
2020 |
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Variants in the Protein Kinase CK2 alpha subunit, encoding the CSNK2A1 gene, have previously been reported in children with an intellectual disability and dysmorphic facial features syndrome: now termed the Okur-Chung neurodevelopmental syndrome.
|
29383814 |
2018 |
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
|
27048600 |
2016 |
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
|
27048600 |
2016 |
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
|
27048600 |
2016 |
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Seizures
|
0.310 |
GeneticVariation
|
phenotype |
BEFREE |
Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures.
|
30655572 |
2019 |
Seizures
|
0.310 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
|
27048600 |
2016 |
Adult T-Cell Lymphoma/Leukemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated molecular analysis of adult T cell leukemia/lymphoma.
|
26437031 |
2015 |
Malignant neoplasm of skin
|
0.300 |
Biomarker
|
disease |
CTD_human |
Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.
|
18572023 |
2008 |
Squamous cell carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.
|
18572023 |
2008 |
Skin Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.
|
18572023 |
2008 |
Myocardial Infarction
|
0.200 |
Biomarker
|
disease |
RGD |
Differential gene expression in infarct scar and viable myocardium from rat heart following coronary ligation.
|
15090263 |
2004 |
Mammary Neoplasms, Experimental
|
0.200 |
Biomarker
|
phenotype |
RGD |
Protein kinase CK2: signaling and tumorigenesis in the mammary gland.
|
11827167 |
2001 |
Dysmorphic features
|
0.120 |
GeneticVariation
|
disease |
CLINVAR |
Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion.
|
29240241 |
2018 |
Dysmorphic features
|
0.120 |
Biomarker
|
disease |
BEFREE |
Taking into account that mutations in CSNK2A1, encoding the α subunit of CK2, were previously identified in patients with neurodevelopmental disorders and dysmorphic features, our study confirmed that the protein kinase CK2 plays a major role in brain, and showed that CSNK2, encoding the β subunit, is a novel ID gene.
|
28585349 |
2017 |
Dysmorphic features
|
0.120 |
GeneticVariation
|
disease |
CLINVAR |
Prevalence and architecture of de novo mutations in developmental disorders.
|
28135719 |
2017 |
Dysmorphic features
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2α, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory (β) and two catalytic (α and/or α') subunits.
|
27048600 |
2016 |
Dysmorphic features
|
0.120 |
GeneticVariation
|
disease |
CLINVAR |
De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
|
27048600 |
2016 |
Dysmorphic features
|
0.120 |
GeneticVariation
|
disease |
CLINVAR |
Presynaptic CK2 promotes synapse organization and stability by targeting Ankyrin2.
|
24395637 |
2014 |
Dysmorphic features
|
0.120 |
GeneticVariation
|
disease |
CLINVAR |
Predominance of CK2α over CK2α' in the mammalian brain.
|
21761202 |
2011 |
Dysmorphic features
|
0.120 |
GeneticVariation
|
disease |
CLINVAR |
The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development.
|
17954558 |
2008 |
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures.
|
30655572 |
2019 |